Literature DB >> 22579236

The preferential targeting of the diseased microvasculature by disk-like particles.

Giulia Adriani1, Marco Donato de Tullio, Mauro Ferrari, Fazle Hussain, Giuseppe Pascazio, Xuewu Liu, Paolo Decuzzi.   

Abstract

Different classes of nanoparticles (NPs) have been developed for controlling and improving the systemic administration of therapeutic and contrast agents. Particle shape has been shown to be crucial in the vascular transport and adhesion of NPs. Here, we use mesoporous silicon non-spherical particles, of disk and rod shapes, ranging in size from 200nm to 1800nm. The fabrication process of the mesoporous particles is described in detail, and their transport and adhesion properties under flow are studied using a parallel plate flow chamber. Numerical simulations predict the hydrodynamic forces on the particles and help in interpreting their distinctive behaviors. Under microvascular flow conditions, for disk-like shape, 1000×400nm particles show maximum adhesion, whereas smaller (600×200nm) and larger (1800×600nm) particles adhere less by a factor of about two. Larger rods (1800×400nm) are observed to adhere at least 3 times more than smaller ones (1500×200nm). For particles of equal volumes, disks adhere about 2 times more than rods. Maximum adhesion for intermediate sized disks reflects the balance between adhesive interfacial interactions and hydrodynamic dislodging forces. In view of the growing evidence on vascular molecular heterogeneity, the present data suggests that thin disk-like particles could more effectively target the diseased microvasculature as compared to spheres and slender rods.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579236      PMCID: PMC3371358          DOI: 10.1016/j.biomaterials.2012.04.027

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  28 in total

1.  Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers.

Authors:  Phapanin Charoenphol; Ryan B Huang; Omolola Eniola-Adefeso
Journal:  Biomaterials       Date:  2009-12-02       Impact factor: 12.479

2.  Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows.

Authors:  Sei-Young Lee; Mauro Ferrari; Paolo Decuzzi
Journal:  Nanotechnology       Date:  2009-11-11       Impact factor: 3.874

3.  Sustained small interfering RNA delivery by mesoporous silicon particles.

Authors:  Takemi Tanaka; Lingegowda S Mangala; Pablo E Vivas-Mejia; René Nieves-Alicea; Aman P Mann; Edna Mora; Hee-Dong Han; Mian M K Shahzad; Xuewu Liu; Rohan Bhavane; Jianhua Gu; Jean R Fakhoury; Ciro Chiappini; Chunhua Lu; Koji Matsuo; Biana Godin; Rebecca L Stone; Alpa M Nick; Gabriel Lopez-Berestein; Anil K Sood; Mauro Ferrari
Journal:  Cancer Res       Date:  2010-05-01       Impact factor: 12.701

4.  A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands.

Authors:  Xiaohua Huang; Xianghong Peng; Yiqing Wang; Yuxiang Wang; Dong M Shin; Mostafa A El-Sayed; Shuming Nie
Journal:  ACS Nano       Date:  2010-10-26       Impact factor: 15.881

Review 5.  Delivering nanomedicine to solid tumors.

Authors:  Rakesh K Jain; Triantafyllos Stylianopoulos
Journal:  Nat Rev Clin Oncol       Date:  2010-09-14       Impact factor: 66.675

Review 6.  More effective nanomedicines through particle design.

Authors:  Jin Wang; James D Byrne; Mary E Napier; Joseph M DeSimone
Journal:  Small       Date:  2011-06-22       Impact factor: 13.281

7.  Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast.

Authors:  Jeyarama S Ananta; Biana Godin; Richa Sethi; Loick Moriggi; Xuewu Liu; Rita E Serda; Ramkumar Krishnamurthy; Raja Muthupillai; Robert D Bolskar; Lothar Helm; Mauro Ferrari; Lon J Wilson; Paolo Decuzzi
Journal:  Nat Nanotechnol       Date:  2010-10-24       Impact factor: 39.213

Review 8.  Physical approaches to biomaterial design.

Authors:  Samir Mitragotri; Joerg Lahann
Journal:  Nat Mater       Date:  2009-01       Impact factor: 43.841

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 10.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

View more
  44 in total

Review 1.  Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Authors:  Prabhani U Atukorale; Gil Covarrubias; Lisa Bauer; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2016-09-15       Impact factor: 15.470

Review 2.  In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.

Authors:  Altug Ozcelikkale; Hye-Ran Moon; Michael Linnes; Bumsoo Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-14

3.  An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles.

Authors:  Randall A Meyer; Randall S Meyer; Jordan J Green
Journal:  J Biomed Mater Res A       Date:  2015-02-24       Impact factor: 4.396

4.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

5.  Rapid Electrostatic Capture of Rod-Shaped Particles on Planar Surfaces: Standing up to Shear.

Authors:  Molly K Shave; Aiste Balciunaite; Zhou Xu; Maria M Santore
Journal:  Langmuir       Date:  2019-09-24       Impact factor: 3.882

Review 6.  Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.

Authors:  Anna Lisa Palange; Roberto Palomba; Ilaria F Rizzuti; Miguel Ferreira; Paolo Decuzzi
Journal:  Mol Ther       Date:  2017-03-22       Impact factor: 11.454

7.  Oncology: Getting physical.

Authors:  Jennie Dusheck
Journal:  Nature       Date:  2012-11-22       Impact factor: 49.962

Review 8.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

9.  Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential.

Authors:  Srimeenakshi Srinivasan; Jenolyn F Alexander; Wouter H Driessen; Fransisca Leonard; Hu Ye; Xuewu Liu; Wadih Arap; Renata Pasqualini; Mauro Ferrari; Biana Godin
Journal:  J Mater Chem B       Date:  2013-10-21       Impact factor: 6.331

Review 10.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.